Themis A Yiaslas1, Ajay Sood1, Gregory Ono1, Tara S Rogers-Soeder1, Rachel E Kitazono1, Janelle Embree1, Cynthia Spann1, Carrie A Caputo1, June Taylor1, Saul Schaefer1. 1. is a Psychologist in the Behavioral Medicine Clinic; is Chief, Endocrine Section; and are Clinical Pharmacists; , and are Dietitians, Nutrition and Food Service; is a Nurse Educator; all at the Sacramento Veterans Affairs Medical Center in California. is a Psychologist, Behavioral Medicine Service, Kaiser Permanente, in Sacramento. Themis Yiaslas is an Assistant Clinical Professor, Department of Psychiatry and Behavioral Sciences, Ajay Sood is Professor, Division of Endocrinology; and is a Professor and Director of Medical Student Research; all at the University of California Davis School of Medicine in Sacramento.
Abstract
BACKGROUND: Heart disease continues to be the leading cause of death in the US, and the number of people with cardiovascular disease (CVD) is rising. CVD is more prevalent among military veterans than nonveterans, and veteran status is associated with higher risk of incident heart disease after controlling for socioeconomic status, other medical diseases, depression, and lifestyle. Many patients seeking care in the Veterans Health Administration, including those who undergo cardiac catheterization, meet the criteria for multimorbidity (defined as ≥ 2 chronic diseases). OBSERVATIONS: The Heart Disease Reversal Program (HDRP) is a novel interdisciplinary, multicomponent lifestyle program at the US Department of Veterans Affairs (VA) Sacramento VA Medical Center. This program is a streamlined adaptation of behavioral/lifestyle interventions aimed at promoting partial reversal (regression) of atherosclerotic heart disease and achievement of comprehensive cardiovascular risk reduction. HDRP was developed and implemented within a VA behavioral medicine clinic and successfully adapted for delivery through videoconferencing during the COVID-19 pandemic. Patient satisfaction survey data indicate a very high level of patient acceptability. We found direct-to-patient clinical outreach an effective method for launching a disease reversal program. CONCLUSIONS: Beyond the clinical benefits to patients, there is significant value and benefit added to the health care system by offering an intervention within the disease reversal paradigm. Efforts of the health care team to reverse a disease can be considered the highest aim of medicine and health care.
BACKGROUND: Heart disease continues to be the leading cause of death in the US, and the number of people with cardiovascular disease (CVD) is rising. CVD is more prevalent among military veterans than nonveterans, and veteran status is associated with higher risk of incident heart disease after controlling for socioeconomic status, other medical diseases, depression, and lifestyle. Many patients seeking care in the Veterans Health Administration, including those who undergo cardiac catheterization, meet the criteria for multimorbidity (defined as ≥ 2 chronic diseases). OBSERVATIONS: The Heart Disease Reversal Program (HDRP) is a novel interdisciplinary, multicomponent lifestyle program at the US Department of Veterans Affairs (VA) Sacramento VA Medical Center. This program is a streamlined adaptation of behavioral/lifestyle interventions aimed at promoting partial reversal (regression) of atherosclerotic heart disease and achievement of comprehensive cardiovascular risk reduction. HDRP was developed and implemented within a VA behavioral medicine clinic and successfully adapted for delivery through videoconferencing during the COVID-19 pandemic. Patient satisfaction survey data indicate a very high level of patient acceptability. We found direct-to-patient clinical outreach an effective method for launching a disease reversal program. CONCLUSIONS: Beyond the clinical benefits to patients, there is significant value and benefit added to the health care system by offering an intervention within the disease reversal paradigm. Efforts of the health care team to reverse a disease can be considered the highest aim of medicine and health care.
Authors: Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert Journal: J Am Coll Cardiol Date: 2011-11-03 Impact factor: 24.094
Authors: Thomas M Maddox; Mary E Plomondon; Megan Petrich; Thomas T Tsai; Hans Gethoffer; Gregory Noonan; Brian Gillespie; Tamara Box; Stephen D Fihn; Robert L Jesse; John S Rumsfeld Journal: Am J Cardiol Date: 2014-09-16 Impact factor: 2.778
Authors: Jenny Koertge; Gerdi Weidner; Melanie Elliott-Eller; Larry Scherwitz; Terri A Merritt-Worden; Ruth Marlin; Lee Lipsenthal; Mimi Guarneri; Robert Finkel; Donald E Saunders; Patty McCormac; Judith M Scheer; Richard E Collins; Dean Ornish Journal: Am J Cardiol Date: 2003-06-01 Impact factor: 2.778
Authors: D Ornish; L W Scherwitz; R S Doody; D Kesten; S M McLanahan; S E Brown; E DePuey; R Sonnemaker; C Haynes; J Lester; G K McAllister; R J Hall; J A Burdine; A M Gotto Journal: JAMA Date: 1983-01-07 Impact factor: 56.272
Authors: D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould Journal: Lancet Date: 1990-07-21 Impact factor: 79.321